Mark Corrigan, Director at Wave Life Sciences Ltd. (WVE), sold 22,630 shares at $13.09 ($309K) on 2025-12-08, disclosed to the SEC on 2025-12-10.
Scheduled sale ($309k) by Director under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $13.09 | 9,600 | $126K | 40.7% |
| 2 | $14.07 | 6,515 | $92K | 29.7% |
| 3 | $14.07 | 6,515 | $92K | 29.7% |
| Total | $13.65 avg | 22,630 | $309K | 100% |
| Filing → |
| CBST | SELL | 2013-05-29 | $764K | — | Filing → |
| ZLCS | SELL | 2013-01-17 | $87K | — | Filing → |
| CBST | SELL | 2012-07-26 | $410K | — | Filing → |